2015-06-23 14:38
＂Ginkgo biloba extract incident＂ affected ShuangDi such as unlimited
|
CNDSN June 23 hearing (Xinhua Lou Yijuan) state food and Drug Administration recently announced the use of illegal Ginkgo biloba extract health food production related to the verification and previous exposure to the part of the law of Ginkgo biloba extract logistics to the 21 health food enterprises, nearly 60% of the raw material has been used, some products have been listed for sale. It is understood that the product has been listed for sale in June 25 days to complete the recall. Up to now, it is found that there are 21 health food enterprises from Guilin Xingda Pharmaceutical Co., Ltd., Ningbo liwah Pharmaceutical Co., Ltd. purchased Ginkgo biloba extract, including Tomson times, and as new well-known enterprises appeared in the announcement of the list published by the State Food and drug administration official website announcement. Attached table: health food enterprises buy Ginkgo biloba extract from the Guilin Xingda, Ningbo Lihua two enterprises
After verification, 21 companies since January 2013 to date of the incident, from Guilin Xingda Pharmaceutical Co., Ltd and Ningbo liwah Pharmaceutical Co., Ltd. purchased Ginkgo biloba extract 8644.32 kg, has sealed material 2208.68 kg, returned materials kg 559.98, destruction of the feedstock kg 785.34, kg 5090.32 other raw materials have been used. It is understood, there are 10 enterprises products have been listed for sale, including: Wuhan Tallyho Biological Products Co., Ltd., Wuhan medtek biology and medicine science and technology limited liability company, Tomson Times Co., Ltd., Guangdong unlimited (China) Co., Ltd., Nu Skin (China), daily health products Co., Ltd., Huzhou branch company, Jinan Weixing biological health care products Co., Ltd., Beijing Yi Luo Shu Biological Technology Co., Ltd., Shanghai Jianlan Biological Products Co., Ltd., Shanghai Tang Xing Bio Technology Co., Ltd., Wuxi jiante Pharmaceutical Co., Ltd.. According to the circular, the relevant provincial food and drug regulatory authorities have verified the product name, batch, flow, quantity and other information, and ordered the enterprise to take measures to seal, recall, etc.. The local food and Drug Supervision Department of the enterprise is to supervise the enterprises to complete the recall work by 25 June. The name of the product recall, batch, flow, quantity and other information will be immediately announced to the public. It is understood that may state food and Drug Administration found that some enterprises in order to reduce the production cost, seek illegal interests, without the processing technology of ginkgo leaf extract from dilute ethanol extraction change for 3% hydrochloric acid extraction, results in the decomposition of effective components of Ginkgo biloba drugs, reduce drug efficacy, and according to the current standard of drug testing method is not found. Guilin Xingda Pharmaceutical Co., Ltd., Ningbo liwah Pharmaceutical Co., Ltd. the two Ginkgo Leaf drug production enterprises suspected of production and operation in hydrochloric acid production process of ginkgo leaf extract, and sales to the health food production enterprises. To ensure the quality and safety of health food, the State Food and drug administration requires all the use of Ginkgo biloba extract production of health food companies should immediately carry out self-examination. 3 Editor: small Shen |
